the writer will repine at no censure which the precipitate publication of mere conjectural suggestions may incur: but shall think himself fully rewarded by having excited the attention of those, who may point out the most appropriate means of relieving a tedious and most distressing malady.
James Parkinson' It is almost 180 years since James Parkinson described his series of patients with what is now known as Parkinson's disease. His own astute clinical observations were unable to discern any obvious aetiology. "On the subject indeed of remote causes, no satisfactory account has yet been obtained from any of the sufferers."' He noted an indulgence in alcohol, lying on damp ground, and the possibility of trauma. He also reported the occupations of three of his patients; one was a gardener, another a sailor, and the third a magistrate. Even in 1817, the disease affected a broad social range of society. We have made some progress in elucidating the cause of Parkinson's disease over this period but this has been limited. For instance, the role of trauma in the aetiology of Parkinson's disease remains uncertain and disputed.2 4 Epidemiological research has steadily increased, particularly over the past 10 years, and more research has been directed towards analytical rather than just descriptive studies. More International comparisons have in the past relied on mortality rates adjusted for demographic differences between countries. Early findings showed a sevenfold to eightfold variation in mortality rates22 23 suggesting an important role for environmental factors as well as possible genetic differences. Mortality rates are susceptible to variations in diagnosis, survival, and certification practice, which could produce large artefactual differences. This is best illustrated by the fivefold mortality differences between Scotland and Japan.22 However, there is little difference in the prevalence rates for patients between 60 and 69 years of age, when underascertainment should be less problematic (Scotland 254/100 0008; Japan 245/100 000).9
More complex approaches differentiate between "multisource" prevalence studies, which rely on the complete identification of patients with a pre-existing diagnosis, and "population based" surveys which screen a total defined population identifying both preexisting and new cases. 24 The population based survey method is particularly important for developing countries because of limited medical services or for communities in which there may be differential access to health care. For example, differential access to health care for ethnic minorities is well recognised in the United States25 and in the Copiah county study, more previously undiagnosed black patients (58%) than white patients (32%) were found. 26 The population based survey method also enables more valid comparisons between studies as ascertainment is more standardised than conventional multisource studies. Unfortunately, as the prevalence rates are usually based on relatively few cases they are less robust, with wide confidence intervals.
Age adjusted prevalence rates suggest that a threefold difference may exist, with Libya (57/100 000) at one end and Iceland (182/ 100 000) at the other.24 Prevalence rates are also susceptible to differences in diagnosis and survival. Artefactual differences can be reduced by limiting the comparison to European countries with good healthcare systems, using incidence rates as these are independent of differences in survival, and comparing rates for subjects under 70 years, in whom underascer- 49 suggest that mortality from Parkinson's disease compared with that of the general population has not altered to a large degree from the prelevodopa days.50 There has been a secular increase in life expectancy for the whole population, so that a patient with Parkinson's disease today would expect to live longer like anyone else in the population. (3) There may have been a genuine change in the incidence of disease: (a) The incidence of disease in elderly people may have increased because of a reduction in heart disease and stroke mortality and hence a decline in competing causes of death.5" If the risk of Parkinson's disease was also associated with heart disease or stroke, a reduction in deaths from heart disease would selectively increase the pool of potential subjects who could develop Parkinson's disease. Only one study has shown such an association49 and this has not been replicated.52 If these diseases are independent of each other, then whereas a reduction of heart disease will increase the absolute number of cases of Parkinson's disease, it will not alter the age specific rates. (b) There has been a decrease in the incidence of disease in young age groups due to a decrease in environmental exposures.'7 (c) The divergence of age specific mortality rates reflects a cohort effect due to a self limiting exposure, such as the encephalitis lethargica epidemic.5'54
Such a hypothesis would predict an increase in mortality as "exposed" cohorts aged but a decline in the mortality of younger age groups who would have been born after the exposure. As these later unexposed cohorts reached old age there would be a subsequent reduction in mortality for all ages. There have been several attempts to examine the cohort hypothesis using mortality data. 
TOXIC EXPOSURES
The report that 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) has neurotoxic The hypothesis that toxins are involved has been given much more credence by the recent discovery that patients with Parkinson's disease have relatively less effective detoxification systems. '22-'26 This enhances the plausibility of the "ecogenetic" hypothesis that Parkinson's disease may result from the combination of an inherited susceptibility and an environmental toxin. If susceptibility is relatively rare-for example, the proportion of the general population with poor metaboliser status for debriso-quine is thought to be between 5% and 10% the exposure may be common as most exposed subjects will not experience any adverse results. From an epidemiological perspective, a common exposure experienced by 80% 
. Personality may therefore either act as a proxy marker of disease, or is a confounding variable unrelated to the disease process. (4) Confounding-There are premorbid personality differences associated with both the likelihood of becoming a smoker and continuing to smoke and other exposures/genes that are directly related to the risk of developing Parkinson's disease. Smokers seem to differ in personality traits from non-smokers and are more likely to be extrovert or exhibit type A behaviour.'39 Non-smokers have higher levels of shyness and defensiveness.'40 Similar personality differences may also determine alcohol consumption. Most studies show that patients with Parkinson's disease either are no different or have reduced alcohol consumption. 90 100 Patients with Parkinson's disease are reported to show personality changes, such as introvertism, that would make them less likely to be smokers.94 105-107 We do not know, however, to what degree personality, such as being the more dominant twin,'07 could influence other risk factors, such as migration from rural to urban areas or reducing the risk of exposure to pesticides. Alternatively certain genes may influence both the tendency to smoke and the risk of developing Parkinson's disease. This argument has been suggested to explain the similar association found with Alzheimer's disease. '41 Head trauma Some studies have noted an excess risk of head trauma among patients with Parkinson's disease than among controls.7495142 This association is usually doubted because of the likelihood that it reflects recall bias. One method to reduce this possible bias is to only measure severe head injuries, such as those resulting in loss of consciousness. Even though such events should be recalled equally well by both cases and controls, patients with Parkinson's disease still show an increased risk.74 Another strategy to control for recall bias is to ask patients about their own "lay beliefs"
as to what caused their disease.'43 Patients who report trauma as a possible cause can then be removed from the analysis to determine the degree of potential bias, although this might underestimate the true risk.144 Only one study has examined a cohort of subjects with recorded head injuries and followed up their risk of Parkinson's disease. This study failed to find any increased risk but had a 30% probability of not detecting a twofold relative risk even if one existed.'08 Susceptibility to trauma, rather than severity itself may be more important. If head injury triggers a cascade of biological events that lead to cell death in only a few susceptible people, then it may be more difficult to detect an increased risk in a head injury cohort than in a case-control study.
Rural residence It is paradoxical that industrialisation has been proposed to explain the differences in geographical prevalence rates between countries, yet within countries residing in a rural area has been noted to increase risk. 77 These specialist centres will often have a wide catchment area and see patients from both urban and rural areas. It is likely that elderly rural patients might be managed locally and not get referred on because of transport and access difficulties.'47 This is not likely for atypical, severe, and young patients and specialist clinics will have an overrepresentation of these. '48 Studies showing an increased risk (except one) selected controls from the hospital which recruited the cases. Controls were usually subjects with more common medical conditions such as heart or respiratory disease and would therefore be more likely to include local urban residents. Such a bias would artefactually increase the proportion of patients with Parkinson's disease from rural areas. The only exception85 used spouses as controls. It is unclear whether spouses might be more or less likely to come from the same area as the patient and this would depend on the level of migration and mixing of urban and rural residents. Studies which failed to show any increased risk used various methods: "buddy" controls,74 neurological clinic controls,90 stratified sampling,8' rheumatoid arthritis controls,77 and population based control selection.'09 The use of buddy controls is not to be recommend as it may well result in overmatching.'49 Selecting patients from a specialist clinic may diminish selection bias but is also problematic especially if a single disease entity is chosen. Only the population based study ensured non-biased ascertainment of both cases and controls'09 and this study failed to show an association. In fact, rural residence in this study may have been associated with a decreased risk for those subjects not exposed to pesticides. As this study showed an increased risk for occupational pesticide use75 and this would be more common in rural areas, the risk for rural subjects not exposed to trauma should be examined. Laboratory work is also needed to examine the biological plausibility of minor trauma precipitating a chain of biochemical events that result in cell death. The association between rural residence, well water consumption, and Parkinson's disease initially seemed to be a consistent and potentially important clue. However, the absence of any association in a population based case-control study is a serious concern as prior results may have been influenced by selection bias. This finding needs confirmation by further suitable studies. Population based prevalence studies comparing stable urban and rural populations in the same country will definitively answer whether there is any excess risk associated with residence in a rural area. The role of dietary factors is still unclear as current evidence is weak. More complex methods of dietary measurement using prospective cohorts would establish whether these results are artefactual.
Comorbidity
The association between Parkinson's disease and other diseases can be a useful clue as to shared common aetiological factors, be they genetic or environmental. Cardiovascular disease, hypertension, and diabetes Heart disease and stroke have been reported to be less common in male patients with Parkinson's disease72 or to be no different from the general population.'57 Most studies which have reported causes of death for patients with Parkinson's disease have used proportional mortality50 158159 and have therefore potentially underestimated the relevance of heart disease compared with the general population.7' One cohort study has reported a twofold to threefold increased risk for both heart disease and stroke compared with normal controls. 49 However, this has not been replicated. 52 Hypertension has either been less common99 157 or no different from control groups.72 79 80 This might relate to abnormalities in autonomic control mechanisms. No increased risk has been seen for diabetes79 80160 despite the experimental finding that fructose blocks MPTP toxicity in isolated hepatocytes.'6' Malignancy Several studies have shown that patients with Parkinson's disease experience about half the number of cancers than would be expected from general population rates.49159 [162] [163] [164] When this is examined in more detail, this deficit is specifically related to smoking related cancers49 162 and is simply explained by the larger proportion of never smokers in the Parkinson's disease population. 
